Abstract:Background: Long noncoding RNAs (lncRNA) provide an additional layer of molecular control in pathways crucial for vascular development and cardiovascular disease. We set out to identify novel endothelial lncRNAs that could be exploited to treat vascular disease. Methods and Results: We identified the endothelial cell-specific long noncoding RNA (lncRNA) PCAT19, which contributes to the endothelial proliferation-quiescence switch and acts as a safeguard for the endothelial genome during quiescence. PCAT19 was upregulated with endothelial cell confluence and quiescence. Knockdown of PCAT19 promoted endothelial proliferation and angiogenic sprouting. Conversely, PCAT19 overexpression reduced endothelial proliferative capacity and angiogenic sprouting. Using a cardiac organoid model system, we observed a markedly denser vascular network after the removal of PCAT19. RNA-sequencing after PCAT19 knockdown revealed multiple differentially regulated cell cycle genes. An antisense-oligonucleotide pulldown of PCAT19 followed by mass spectrometry identified multiple DNA damage response and cell cycle-related proteins as PCAT19 interaction partners; among them was the full DNA replication protein A complex. PCAT19 knockdown was found to sensitise DNA to damage, as measured by heightened p53 and γH2AX levels as well as a positive TUNEL signal and longer comet tail olive moments. Mechanistically, PCAT19 limited the phosphorylation of RPA2 on the serine 33 (S33) residue by inhibiting RPA2 interaction with the ATR kinase. Conclusions: In healthy vessels, endothelial cells maintain a stable, differentiated and growth-arrested phenotype. Upon injury, a rapid phenotypic switch facilitates proliferation to restore tissue perfusion. PCAT19 was identified as a highly enriched endothelial lncRNA that acts as a dynamic guardian of the endothelial genome, promotes cellular longevity and facilitates rapid switching to proliferation. Therapeutic targeting of PCAT19 could potentially alter the course of vascular disease development and progression by modulating endothelial growth and angiogenic sprouting.

A phosphodiesterase pathway essential for lymphangiogenic growth arrest and maturation

A Role for Planar Cell Polarity Signaling in Angiogenesis

The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling

Activation of the Planar Cell Polarity Formin Daam1 Leads to Inhibition of Endothelial Cell Proliferation, Migration, and Angiogenesis

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Genetic Dissection of Tie Pathway in Mouse Lymphatic Maturation and Valve Development

Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function

Angiomotin-Like2 Gene (amotl2) is Required for Migration and Proliferation of Endothelial Cells During Angiogenesis

Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis

Akt/Protein Kinase B is Required for Lymphatic Network Formation, Remodeling, and Valve Development.

Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis

PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis

VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels

Abstract P2058: LncRNA PCAT19 Limits Angiogenesis And Safeguards Quiescent Endothelial DNA By Preventing Uncontrolled Phosphorylation Of Replication Protein A2

Edg-1, the G Protein-Coupled Receptor for Sphingosine-1-phosphate, is Essential for Vascular Maturation.

The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function

Protein phosphatase 2A regulates blood cell proliferation and differentiation in Drosophila larval lymph glands

Cell Proliferation and Migration Are Modulated by Cdk-1-Phosphorylated Endothelial-Monocyte Activating Polypeptide II

Dll4 and Notch signalling couples sprouting angiogenesis and artery formation

Foxc1 and Foxc2 Deletion Causes Abnormal Lymphangiogenesis and Correlates with ERK Hyperactivation.

Lysophosphatidic Acid Acts As a Nutrient‐derived Developmental Cue to Regulate Early Hematopoiesis